Thrivent Financial for Lutherans Portfolio holdings
AUM
$45.7B
1-Year Return
20.42%
This Quarter Return
-6.33%
1 Year Return
+20.42%
3 Year Return
+83.29%
5 Year Return
+151.37%
10 Year Return
+389.71%
AUM
$19.1B
AUM Growth
+$948M
(+5.2%)
Cap. Flow
+$2.62B
Cap. Flow
% of AUM
13.75%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
1,945
New
92
Increased
1,208
Reduced
328
Closed
152
Top Buys
| 1 |
Microsoft
MSFT
|
+$182M |
| 2 |
Equifax
EFX
|
+$53.5M |
| 3 |
CERN
Cerner Corp
CERN
|
+$49.7M |
| 4 |
Albemarle
ALB
|
+$47.4M |
| 5 |
Masco
MAS
|
+$47M |
Top Sells
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$82.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$73M |
| 3 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$69.6M |
| 4 |
Baxter International
BAX
|
+$65.5M |
| 5 |
Teradata
TDC
|
+$52.5M |
Sector Composition
| 1 | Financials | 15.59% |
| 2 | Technology | 13.11% |
| 3 | Consumer Discretionary | 12.4% |
| 4 | Healthcare | 11.12% |
| 5 | Industrials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PX
951
DELISTED
Praxair Inc
PX
| $800K | ﹤0.01% |
7,850
+350
| +5% | +$35.7K |
|
952
Pediatrix Medical
MD
$1.48B
| $799K | ﹤0.01% |
10,400
+850
| +9% | +$65.3K |
|
953
ResMed
RMD
$40.2B
| $798K | ﹤0.01% |
15,650
+1,300
| +9% | +$66.3K |
|
954
Emerson Electric
EMR
$77.4B
| $797K | ﹤0.01% |
18,050
-2,302
| -11% | -$102K |
|
|
RYL
955
DELISTED
RYLAND GROUP INC
RYL
| $796K | ﹤0.01% |
19,500
+1,250
| +7% | +$51K |
|
|
UNT
956
DELISTED
UNIT Corporation
UNT
| $795K | ﹤0.01% |
+70,600
| New | +$795K |
|
|
VSI
957
DELISTED
Vitamin Shoppe Inc.
VSI
| $792K | ﹤0.01% |
24,250
+12,550
| +107% | +$410K |
|
|
BRCM
958
DELISTED
BROADCOM CORP CL-A
BRCM
| $784K | ﹤0.01% |
15,250
+1,100
| +8% | +$56.6K |
|
959
Quanex
NX
$697M
| $783K | ﹤0.01% |
43,075
+29,800
| +224% | +$542K |
|
960
Marriott Vacations Worldwide
VAC
$2.75B
| $777K | ﹤0.01% |
11,400
-18,440
| -62% | -$1.26M |
|
|
B
961
DELISTED
Barnes Group Inc.
B
| $770K | ﹤0.01% |
21,350
+2,150
| +11% | +$77.5K |
|
962
Darling Ingredients
DAR
$5.05B
| $768K | ﹤0.01% |
68,350
+3,900
| +6% | +$43.8K |
|
|
CB
963
DELISTED
CHUBB CORPORATION
CB
| $767K | ﹤0.01% |
6,250
+320
| +5% | +$39.3K |
|
964
Idexx Laboratories
IDXX
$51.6B
| $765K | ﹤0.01% |
10,300
+800
| +8% | +$59.4K |
|
965
Moog
MOG.A
$6.38B
| $762K | ﹤0.01% |
14,100
-1,050
| -7% | -$56.7K |
|
966
Marsh & McLennan
MMC
$100B
| $760K | ﹤0.01% |
14,550
+600
| +4% | +$31.3K |
|
967
Becton Dickinson
BDX
$54.6B
| $759K | ﹤0.01% |
5,868
-451
| -7% | -$58.3K |
|
|
XLRN
968
DELISTED
Acceleron Pharma Inc.
XLRN
| $757K | ﹤0.01% |
30,420
-6,850
| -18% | -$170K |
|
969
State Street
STT
$32B
| $756K | ﹤0.01% |
11,250
+550
| +5% | +$37K |
|
970
TETRA Technologies
TTI
$644M
| $756K | ﹤0.01% |
127,950
+96,950
| +313% | +$573K |
|
971
Axos Financial
AX
$5.21B
| $754K | ﹤0.01% |
23,400
+2,400
| +11% | +$77.3K |
|
972
CACI
CACI
$10.8B
| $747K | ﹤0.01% |
10,100
+700
| +7% | +$51.8K |
|
973
Strategy Inc Common Stock Class A
MSTR
$92.4B
| $747K | ﹤0.01% |
38,000
+2,000
| +6% | +$39.3K |
|
974
MKS Inc. Common Stock
MKSI
$7.79B
| $744K | ﹤0.01% |
22,200
+1,350
| +6% | +$45.2K |
|
975
Winnebago Industries
WGO
$988M
| $744K | ﹤0.01% |
38,850
+28,300
| +268% | +$542K |
|